Tarek Harb

Johns Hopkins University

H指数:8

被引数:395

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lp(a) in Argentina: Regional data reinforce a global risk factor

阿根廷Lp(a)：区域数据强化了全球性风险因素

Atherosclerosis

IF5.7

2025-11-170

PRE

Oxidized phospholipids (OxPLs) dynamics following acute myocardial infarction (MI): effects of PCSK9 inhibition with evolocumab

European Heart Journal

IF35.6

2025-11-050

PRE

The biology of lipoprotein(a): From genetics to molecular mechanisms

脂蛋白(a)的生物学：从遗传学到分子机制

European Journal of Clinical Investigation

IF3.6

2025-10-030

PRE

Lipoprotein(a) in clinical practice: Risk stratification and therapeutic strategies

脂蛋白(a)在临床实践：风险分层和治疗策略

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IF3.6

2025-10-011

PRE

Oxidized Phospholipid Dynamics in the Early Post-Infarction Period: Effects of PCSK9 Inhibition with Evolocumab

心肌梗死早期后期的氧化磷脂动态：Evolocumab介导的PCSK9抑制的影响

Atherosclerosis

IF5.7

2025-08-050

OAAI

Increased Lipoprotein(a) Levels Independently Predict a Higher Incidence of Ventricular Arrhythmias: A Comprehensive Retrospective Cohort Study

Lipoprotein(a)水平升高可独立预测室性心律失常发生率的增加：一项全面的回顾性队列研究

heart rhythm

IF2.9

2025-07-070

OAAI

Impact of In-Hospital PCSK9 Inhibition on Myocardial Inflammation After Myocardial Infarction

心肌梗死患者住院期间应用PCSK9抑制剂对心肌炎症的影响

jacc basic to translational science

IF0

2025-05-280

Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel disease

先进生物疗法与炎症性肠病患者的心血管事件

American Journal of Preventive Cardiology

IF5.9

2025-04-240

OAAI

Vericiguat prevents high glucose-mediated impaired vascular smooth muscle cGMP production and vasorelaxation

SCIENTIFIC REPORTS

IF3.9

2025-02-100

OAAI

Peroxisome proliferator-activated receptor gamma regulates interleukin-6 induced lipoprotein(a) gene expression in human HepG2 cells

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Intraindividual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate-risk

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Advanced biologic therapies are associated with fewer adverse cardiovascular events in patients with inflammatory bowel diseases

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Emerging clinical role of proprotein convertase subtilisin/kexin type 9 inhibition-Part 2: Current and emerging concepts in the clinical use of PCSK9 inhibition

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IF3.6

2024-06-265

PRE

Emerging clinical role of proprotein convertase subtilisin/kexin type 9 inhibition-Part one: Pleiotropic pro-atherosclerotic effects of PCSK9

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IF3.6

2024-06-262

PRE

Defining Misinformation and Related Terms in Health-Related Literature: Scoping Review

健康相关文献中虚假信息及相关术语的界定：范围综述

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2023-08-0917

OAAI

Efficacy of lung cancer screening at the American University of Beirut Medical Center

FRONTIERS IN ONCOLOGY

IF3.3

2023-08-040

OAAI

Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

IF6.1

2023-07-1911

PRE

Novel Diagnostic Imaging Approach for Patients With Spontaneous Coronary Artery Dissection The Utility of 18F-FDG PET Imaging

自发性冠状动脉夹层患者的新诊断成像方法18F-FDG PET成像的应用

CLINICAL NUCLEAR MEDICINE

IF9.6

2023-06-290

PRE

A Framework for the Development of Living Practice Guidelines in Health Care

ANNALS OF INTERNAL MEDICINE

IF15.2

2022-08-0141

PRE

Theoretical calculation of the low lying electronic states of the molecular ion RbH+ with spin-orbit effects

具有自旋轨道效应的分子离子RbH低电子态的理论计算

JOURNAL OF CHEMICAL PHYSICS

IF3.1

2008-11-245

PREAI

Tarek Harb

个人简介

教育背景

工作经历

荣誉奖项

研究方向